msp3 vaccine
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2007 (NCT00469651)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- msp3 vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00469651 | Phase 1 | Oct 1, 2007 | African Malaria Network Trust, National Institute For Medical Research in Tanzania, National Institute for Medical Research, Tanzania, University of London |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| African Malaria Network Trust | Academic/Hospital | 1 | 1 | 1 | 2007 |
| National Institute For Medical Research in Tanzania | Government | 1 | 0 | 1 | 2007 |
| National Institute for Medical Research, Tanzania | Government | 1 | 0 | 1 | 2007 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2007 |
4 organizations
Page 1 / 1